Ausgabe 3/2018
Inhalt (20 Artikel)
Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells
Zuhal Hamurcu, Nesrin Delibaşı, Seda Geçene, Elif Funda Şener, Hamiyet Dönmez-Altuntaş, Yusuf Özkul, Halit Canatan, Bulent Ozpolat
MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment
Xiaoyue Xu, Shaorong Yu, Wenbo Sun, Xiaobing Qin, Yan Chen, Leilei Zhou, Rui Lou, Shuchen Dong, Bo Shen, Jianzhong Wu, Jialan Zang, Haixia Cao, Meiqi Shi, Qin Zhang, Jifeng Feng
A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma
Ruichao Chai, Kenan Zhang, Kuanyu Wang, Guanzhang Li, Ruoyu Huang, Zheng Zhao, Yanwei Liu, Jing Chen
Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia
Wen-Ting Wang, Hua-Yuan Zhu, Yu-Jie Wu, Yi Xia, Jia-Zhu Wu, Wei Wu, Jin-Hua Liang, Li Wang, Lei Fan, Jian-Yong Li, Wei Xu
Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma
Dhiraj Sikaria, Yaping N. Tu, Diana A. Fisler, James A. Mauro, George Blanck
Ecto-5′-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line
Fabrícia Dietrich, Fabrício Figueiró, Eduardo Cremonese Filippi-Chiela, Angélica Regina Cappellari, Liliana Rockenbach, Alain Tremblay, Patrícia Boni de Paula, Rafael Roesler, Aroldo Braga Filho, Jean Sévigny, Fernanda Bueno Morrone, Ana Maria Oliveira Battastini
MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells
Luciano Mazzoccoli, Marcela Cristina Robaina, Alexandre Gustavo Apa, Martin Bonamino, Luciana Wernersbach Pinto, Eduardo Queiroga, Carlos E. Bacchi, Claudete Esteves Klumb
Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model
Hans D. Menssen, Ulf Harnack, Ulrike Erben, Dario Neri, Burkhard Hirsch, Horst Dürkop
High nuclear MSK1 is associated with longer survival in breast cancer patients
Xuan Pu, Sarah J. Storr, Narmeen S. Ahmad, Emad A. Rakha, Andrew R. Green, Ian O. Ellis, Stewart G. Martin
Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor
Gabrielle Karpinsky, Malgorzata A. Krawczyk, Ewa Izycka-Swieszewska, Aleksandra Fatyga, Agnieszka Budka, Walentyna Balwierz, Grazyna Sobol, Beata Zalewska-Szewczyk, Magdalena Rychlowska-Pruszynska, Teresa Klepacka, Bozenna Dembowska-Baginska, Bernarda Kazanowska, Anna Gabrych, Ewa Bien
Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis
Wenkang Luan, Zhou Zhou, Xin Ni, Yun Xia, Jinlong Wang, Yulan Yan, Bin Xu
Risk for cancer in living kidney donors and recipients
Min Wang, Huai Zhang, Dan Zhou, Yong-Chao Qiao, Yan-Hong Pan, Yan-Chao Wang, Hai-Lu Zhao
The use of complementary and alternative medicine by patients in routine care and the risk of interactions
Rachel Firkins, Hannah Eisfeld, Christina Keinki, Jens Buentzel, Andreas Hochhaus, Thorsten Schmidt, Jutta Huebner
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach
Harald Schmalenberg, Salah-Eddin Al-Batran, Claudia Pauligk, Thomas Zander, Alexander Reichart, Udo Lindig, Mathias Kleiß, Lothar Müller, Claus Bolling, Thomas Seufferlein, Peter Reichardt, Frank Kullmann, Henning Eschenburg, Alexander Schmittel, Matthias Egger, Andreas Block, Thorsten Oliver Goetze
Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: results of the IBuTu study
Friedemann Honecker, Ulrich Wedding, Gerd Kallischnigg, Axel Schroeder, Jörg Klier, Thomas Frangenheim, Lothar Weißbach
Influence of physical activity on the immune system in breast cancer patients during chemotherapy
Thorsten Schmidt, Walter Jonat, Daniela Wesch, Hans-Heinrich Oberg, Sabine Adam-Klages, Lisa Keller, Christoph Röcken, Christoph Mundhenke
CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation
Judith Hammrich, Susan Wittig, Thomas Ernst, Bernd Gruhn
Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer: a 22-year bicentre study
Sara Acciuffi, Frank Meyer, Astrid Bauschke, Utz Settmacher, Hans Lippert, Roland Croner, Annelore Altendorf-Hofmann
Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR
Daniele Generali, Silvia Paola Corona, Lajos Pusztai, Roman Rouzier, Giovanni Allevi, Sergio Aguggini, Manuela Milani, Carla Strina, Albane Frati
Decision tree analysis to stratify risk of de novo non-melanoma skin cancer following liver transplantation
Tomohiro Tanaka, Michael D. Voigt